<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="2746">
  <stage>Registered</stage>
  <submitdate>26/04/2010</submitdate>
  <approvaldate>26/04/2010</approvaldate>
  <nctid>NCT01111409</nctid>
  <trial_identification>
    <studytitle>A Pilot Study to Evaluate the Clinical Effectiveness and Safety of the VFIX Device as Treatment for Apical Prolapse</studytitle>
    <scientifictitle>A Prospective, Multi-Centre Pilot Study to Evaluate the Clinical Effectiveness and Safety of the VFIX Device as Treatment for Apical Prolapse</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>300-08-013</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Pelvic Organ Prolapse</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Research that is not of generic health relevance and not applicable to specific health categories listed above</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fetal medicine and complications of pregnancy</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - VFIX Device

Experimental: VFIX - 


Treatment: devices: VFIX Device
Sterile, single-use instrument capable of delivering an absorbable PDS suture anchor

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes />
  <eligibility>
    <inclusivecriteria>-  Age greater than or equal to 18 years

          -  Subjects of child bearing potential have a negative blood or urine pregnancy test
             prior to the procedure and subject has completed childbearing

          -  Subject with apical prolapse at stage II or more and requiring treatment (C should be
             at least -1 cm)

          -  On reduction of the apical prolapse, leading edge of prolapse should be at or above
             the hymen

          -  If applicable, subject has small/normal size uterus and there is no elongation of the
             cervix as determined by clinical assessment

          -  The vaginal apex can reach the Sacrospinous Ligament (SSL) on exam

          -  Subjects are allowed concurrent incontinence procedure as required

          -  Concurrent perineal repairs and excision of excess vaginal tissue repairs as required

          -  Agrees to participate in the study, including completion of all study-related
             procedures, evaluations and questionnaires, and documents this agreement by signing
             the Ethics Committee approved informed consent</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Female</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Additional surgical intervention for POP repairs concurrent to the VFIX procedure
             (including, but not limited to sacrocolpopexy, paravaginal repair, colporrhaphy, mesh
             repair, etc)

          -  Experimental drug or experimental medical device within 3 months prior to the planned
             procedure

          -  Active genital, urinary or systemic infection at the time of the surgical procedure.
             Surgery may be delayed in such subjects until the infection is cleared.

          -  Previous hysterectomy within 6 months of scheduled surgery.

          -  Coagulation disorder or on therapeutic anticoagulant therapy (except aspirin) at the
             time of surgery

          -  Nursing or pregnant

          -  Presence of cancers of the vagina, cervix, or uterus

          -  In the investigator's opinion, any medical condition or psychiatric illness that could
             potentially be life threatening or affect their ability to complete the study visits
             according to this protocol</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/03/2010</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>20</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/06/2011</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>QEII Hospital - Brisbane</hospital>
    <hospital>Frances Perry House - Parkville</hospital>
    <hospital>Urogynaecology Unit, Royal Women's Hospital - Parkville</hospital>
    <postcode>QLD 4108 - Brisbane</postcode>
    <postcode>VIC 3052 - Parkville</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Ethicon, Inc.</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary objective of this pilot study is to evaluate the safety and effectiveness of the
      VFIX device in maintaining vaginal apical support for at least 6 months in women with
      symptomatic apical prolapse (upper vaginal or uterine prolapse).</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01111409</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>David Robinson, MD</name>
      <address>Ethicon, Inc.</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>